Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives.
about
Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary studyThe diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives.Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase.Ovarian cycle-linked plasticity of δ-GABAA receptor subunits in hippocampal interneurons affects γ oscillations in vivo.Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensusEcological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigueOral contraceptives and mood.Premenstrual syndrome and premenstrual dysphoric disorder in perimenopausal women.Characterization of symptoms and edema distribution in premenstrual syndromeTreatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopauseReproductive hormonal treatments for mood disorders in women.Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Effects of endogenous and exogenous progesterone on emotional intelligence in cocaine-dependent men and women who also abuse alcohol.Neurosteroids and GABA-A Receptor Function.Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and womenA comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms.The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women.ISPMD consensus on the management of premenstrual disorders.GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.Oral contraception and cyclic changes in premenstrual and menstrual experiences.A controlled trial of Chinese herbal medicine for premenstrual syndrome.Acute intermittent porphyria symptoms during the menstrual cycle.Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity.Ovulation disturbances and mood across the menstrual cycles of healthy women.Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.The influence of premenstrual symptoms on postural balance and kinesthesia during the menstrual cycle.
P2860
Q33589728-B80875FB-25BB-453A-AF15-5A574CEC66B9Q33985199-23D136CB-9056-46EC-A579-E871EDD50C61Q34023828-7839C944-C42E-425B-892A-953AD402934EQ34025794-16E5CA75-0BDE-49A6-9F54-63BAEAEB9C05Q34053506-EB92D1D1-3935-4993-94AB-77A832F9EAECQ34172776-762B08F8-1F22-4150-8210-8F1D69FE7F04Q34390323-4519FE32-EE93-4AC3-AF68-B9997E420B55Q34391183-2DC78BBC-695F-41A5-9978-7D325C34255BQ35185730-990541CA-4354-48F8-85A0-FC99719471C7Q35236462-C442F708-AC60-4508-B160-11578B812FCDQ35236472-5A42AC78-5A93-4FA4-8744-62E9E2991DBBQ35575008-1181316B-F2E1-41D3-AADB-4D12CA8457C4Q35681226-560D1BBA-18C3-4AC2-99C1-4B0A172B9E5DQ35841963-2842D7BA-346C-41A9-A608-01D970AF9EEEQ35971833-96062358-E42C-45C9-A7C6-EFBB74E2665FQ36578128-8BD88FBE-3CF2-479C-A079-4A2819178B06Q36720116-06EC3A3D-2CEA-470C-ADC1-8805D3187411Q37364646-CB2BB65A-3F47-46B7-AF6B-B8E663447ED4Q37638987-B22B6674-6565-435A-AF2A-F9DD259535FCQ38591320-FB9F35C9-73F6-4EA1-8EF3-1B6042E4373BQ43558683-27AC76D6-C751-4004-AD93-21F995192BE6Q44635978-B470B055-BE04-42BD-A899-466E4BE9D149Q47672085-C403A3A5-E6C2-49A0-8775-5828D707287FQ47830449-6C16994A-5AB2-48E0-82BA-AA4953D4F007Q48785931-E936E379-B047-452F-AFAF-1175CE326E5AQ50724508-4F4F0BE7-7AE0-4FE9-B5FE-B135DB65742DQ50930910-7238BB9C-4B87-49F9-B18B-D0004E695E88Q51707430-116379AE-A8A8-4583-B4A6-B98EF2F1B5D2
P2860
Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Prevalence of menstrual cycle ...... not using oral contraceptives.
@en
Prevalence of menstrual cycle ...... not using oral contraceptives.
@nl
type
label
Prevalence of menstrual cycle ...... not using oral contraceptives.
@en
Prevalence of menstrual cycle ...... not using oral contraceptives.
@nl
prefLabel
Prevalence of menstrual cycle ...... not using oral contraceptives.
@en
Prevalence of menstrual cycle ...... not using oral contraceptives.
@nl
P1476
Prevalence of menstrual cycle ...... not using oral contraceptives.
@en
P2093
Bäckström T
Sveindóttir H
P304
P356
10.1080/J.1600-0412.2000.079005405.X
P577
2000-05-01T00:00:00Z